• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mayo Clinic joins call for increased screening for HPV-related cancers

Bioengineer by Bioengineer
June 7, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ROCHESTER, Minn. – Mayo Clinic Cancer Center joined 69 other National Cancer Institute-designated cancer centers in calling for increased HPV vaccination and screening to eliminate HPV-related cancers. Participating centers issued a joint statement.

According to the statement, nearly 80 million Americans – 1 out of every 4 people – are infected with HPV, and more than 31,000 of these people will be diagnosed with an HPV-related cancer this year. Despite those statistics and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination rates remain low in the U.S.

"The HPV vaccine is a proven way to prevent certain types of cancer, but it's not being used widely enough," says Robert Diasio, M.D., director of the Mayo Clinic Cancer Center. "We want people to know this is an opportunity to prevent cancer and save lives."

Vaccination rates remain significantly lower than other recommended adolescent vaccines in the U.S. According 2016 data from the Centers for Disease Control (CDC), less than 50 percent of girls and 38 percent of boys completed the recommended vaccine series. Research shows there are numerous barriers to overcome to improve vaccination rates. Health care providers are not strongly recommending vaccination. Also, parents do not understand that this vaccine protects against several types of cancer, including cervical, anal, oropharyngeal (middle throat) and other genital cancers.

HPV experts from the nation's top cancer centers, along with partners from the National Cancer Institute, CDC and the American Cancer Society, are meeting June 7 – 8 in Salt Lake City to discuss a path forward to eliminating cancers caused by HPV, including reducing barriers to vaccination, as well as sharing education, training and intervention strategies to improve vaccination rates.

###

About Mayo Clinic Cancer Center

As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call the clinical trials referral office at 1-855-776-0015 (toll-free)

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing. Learn more about Mayo Clinic. Visit the Mayo Clinic News Network.

Media Contact

Joe Dangor
[email protected]
507-284-5005
@MayoClinic

http://www.mayoclinic.org/news

https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-joins-call-for-increased-screening-for-hpv-related-cancers/

Share12Tweet7Share2ShareShareShare1

Related Posts

Tamibarotene Drives Neuroblastoma Cell Differentiation via PI3K/AKT

September 5, 2025

Unveiling KRTAP5-AS1/miR-199b-5p/CYP19A1 in PCOS

September 5, 2025

Navigating Physician-Patient Persuasion: Medical Students’ Views

September 5, 2025

Chitosan Formulations: Innovations in Therapeutic Applications

September 5, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tamibarotene Drives Neuroblastoma Cell Differentiation via PI3K/AKT

Unveiling KRTAP5-AS1/miR-199b-5p/CYP19A1 in PCOS

Coral-Inspired Pill Reveals Insights into the Gut’s Hidden Ecosystem

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.